Hiraoka, Masakazu
Maeda, Akiko
Yamamoto, Midori
Gofas-Salas, Elena
Kitahata, Shohei
Yokota, Satoshi
Togashi, Yuki
Toshimori, Masanao
Kimura, Shuhei
Hirami, Yasuhiko
Kurimoto, Yasuo
Gocho, Kiyoko
Funding for this research was provided by:
Santen
Article History
Received: 25 November 2025
Accepted: 3 June 2026
First Online: 7 June 2026
Change Date: 18 September 2026
Change Type: Update
Change Details: The original online version of this Article was revised: In the original version of this Article the name of author surnames and given names were reversed. The original Article has been corrected.
Declarations
Competing interests: A.M. received a financial support from Santen. Y.T. and M.T. are employees of Santen. H.M., M.Y., E.G., S.Y., S.K., Y.H., Y.K., and K.G. declare no competing interests.
Ethics declaration: The study was approved by the Research Review Committee of Kobe City Kobe Eye Center Hospital (Permit No.: ek241201) and by the Institutional Review Board at the Research Committee of Santen Pharmaceutical Co., Ltd. The study was registered at the University Hospital Medical Information Network Clinical Trials Registry (clinical trial identifier: UMIN000057025).
Consent to participate: Before collecting data from the patients, written informed consent was obtained in accordance with the guidelines of the Declaration of Helsinki.